Short Course
Assessment and Medical Evaluation of Individual Case Safety Reports (Online)
Venue
Online
Date
21 October 2026 - 22 October 2026
Course overview
Our Assessment and Medical Evaluation of Individual Case Safety Reports (ICSRs) is an interactive course designed to provide you with the necessary skills and knowledge required to assess ICSRs. You will review reports from various sources both from a regulatory and clinical perspective as well as understand medical review of Individual Case Safety Reports for causality and seriousness purposes. Evaluation of a cluster of reports or case series will be discussed, in addition to guidance regarding MedDRA coding of certain types of events and special situations such as off label use, as well as reports from literature and management of third parties.
The course covers the current and future requirements for the production of case narratives, at an individual level and within regulatory submissions such as periodic benefit risk evaluation reports. Importantly, the course provides a detailed view of the journey of an individual case safety report from receipt to submission. Practical coaching takes place in small groups where delegates have the opportunity to discuss individual scenarios and receive feedback from expert tutors from Regulators and Industry.
As well as being suitable for those new to ICSRs, the course will cover up-to-date information making it a good refresher for those with more experience.
Please note, the course dates and programme may be subject to change.
Who should attend
This course is aimed at:
- Pharmaceutical industry personnel from areas including pharmacovigilance, clinical research, medical affairs, medical writing, regulatory affairs and medical information
- Staff from regulatory authorities
As well as being suitable for those new to ICSRs, the course will cover up-to-date information making it a good refresher for those with more experience.
How the course works
- Taught over two days online
- A combination of lectures and interactive workshops
- Interact with other delegates and speakers via scheduled discussion sessions
- Full access to PDFs and recordings of the presentations afterwards
- Use this course as part of your Continuing Professional Development (CPD)
- Delegates will be sent a Teams link in advance to enable you to join the live course at the stated time
- Certificate of attendance provided upon completion of the course
Our fees
Registration fees include electronic access to all course materials.
Please note, VAT is only applicable for delegates based in the UK.
Cost Per Delegate:
Academic
£775 + VAT
(Academic Units, Public Sector Organisations, Registered Charities
Standard
£1190 + VAT
Aims of the course
- To enable delegates to acquire and practice the skills necessary for producing well written case narratives for reporting to regulatory authorities and for research reports
- To introduce delegates to the relevant regulatory requirements and the need to clear definitions and procedures for the reports of Adverse Drug Reactions
Learning outcomes
On successful completion of this course delegates should be able to:
- Relate the complexity of medical history taking into account challenges faced in producing good quality case narratives
- Define and appraise the critical data elements needed from reporting sources to complete a safety report
- Critically analyse an individual adverse event as to whether it is reportable and provide recommendations as to whether reporting should be expedited
Programmed features
- Assessment of reports from various sources both from a regulatory and a clinical perspective
- Evaluation of a cluster of reports/ case series
- Coding of atypical events
- Current and future requirements for the production of case narratives
Download programme
Please download the relevant programme for your chosen course date.
21 October 2026 - 22 October 2026
Book now
- 21 October 2026 - 22 October 2026
Limited places available - register early to secure your spot
Our courses are CPD accredited by the Faculty of Pharmaceutical Medicine and are recognised by PharmaTrain.
